Immunome's total assets for Q2 2025 were $296.29M, a decrease of -13.54% from the previous quarter. IMNM total liabilities were $27.02M for the fiscal quarter, a -24.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.